Research Article

[Retracted] Diagnostic Values of Advanced Glycation End Products and Homocysteine in Patients with Alzheimer’s Disease and Sarcopenia

Table 1

Basic data in four groups.

ItemNCSPADAD+SP

Age (year)<0.001
Gender
 Male19 (65.52)40 (61.52)23 (58.97)20 (57.14)0.763
 Female10 (34.48)25 (38.45)16 (41.03)15 (42.86)
BMI ()<0.001
Comorbidity
 Hypertension21 (72.41)36 (55.37)34 (69.23)27 (77.14)0.008
 DM15 (51.72)24 (36.91)35 (89.74)14 (40.00)0.012
Cardiovascular disease9 (31.03)21 (32. 30)16 (41.03)15 (42.86)0.071
Cerebrovascular disease19 (65.52)38 (58.44)24 (61.54)29 (82.85)0.032
Osteoporosis7 (24.08)31 (47.68)9 (23.08)11 (31.43)<0.001
Education level
 ≤6 years1 (3.44)4 (6.15)6 (15.38)2 (5.71)<0.001
 >6 years and <12 years14 (48.16)28 (43.06)20 (51.28)26 (74.29)
 ≥12 years13 (44.72)33 (50.75)12 (30.77)8 (22.86)
Currently smoking3 (10.32)3 (4.61)3 (7.69)2 (5.71)0.407
Falls in the last 12 months8 (27.52)2 (33.83)12 (30.77)9 (25.71)0.476
Daily kinds17 (58.48)34 (52.29)26 (66.66)22 (62.85)0.243
Depression1 (3.44)9 (13.84)7 (17.95)7 (20.00)<0.001
Malnutrition2 (6.88)18 (27.68)8 (20.51)21 (60.00)<0.001